Atlantia, Continental, Intel Capital, Klocke, NTTVC and Tokyo Century were among the investors in a round that took the air taxi developer’s overall funding to near $390m.

The Vertex Pharmaceuticals-backed genomic analytics platform developer has now raised approximately $88m in funding altogether.

Q&A with Wanja Humanes, investment manager, Swisscom Ventures

The instalment finance provider, which counts several corporates as investors, almost tripled its valuation to $31bn in the round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Condé Nast and Kering joined new and returning investors to back a round valuing the fashion item resale platform in excess of $1bn.

Karolinska Development has named Per Aniansson has its chief financial officer and investment director to replace Fredrik Järrsten.

Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.

IP Group and V-Bio have backed a round that will support phase 2 trials for a treatment for diabetic macular edema.

The vehicle will invest in all winners of the Venture Kick competition and will provide follow-on funding in two subsequent rounds.